How low can we go: Achieving postoperative day 1 discharge after deep inferior epigastric perforator, a safe and feasible goal.
Abstract
[BACKGROUND] Although rare reports describe discharge to be possible within 48 hours for patients undergoing autologous breast reconstruction, average length of stay remains around 3 days. This study aimed to demonstrate that patients can be safely discharged within 1 day after deep inferior epigastric perforator (DIEP) flap breast reconstruction.
[METHODS] A retrospective review was performed of patients who underwent free flap breast reconstruction by a single surgeon from November 2021 to May 2024. Demographics, operative details, opioid ingestion, length of stay, and postoperative complications were reviewed to assess safety of discharge in 24 hours.
[RESULTS] One hundred sixty-four DIEP flaps were performed on 119 patients. Average length of stay was 1.5 days (SD 0.7 days), with 67 (56.3%) patients discharged on postoperative day 1 (POD1) and 52 (43.7%) discharged after POD1. Of those discharged on POD1, 13 (19.4%) went home in <24 hours. Comparing patients discharged on POD1 to those discharged after POD1, there were statistically significant differences in reconstruction laterality (76.1% vs 44.2% unilateral, p<0.001), operative time (341.0 vs 439.1 minutes, p<0.001), and opioid ingestion on POD1 (4.2 IV morphine milligram equivalents [MME] vs 11.3 MME, p<0.001). Common complications included abdominal wound dehiscence (10.1%), abdominal seroma (5.0%), breast wound dehiscence (4.9%), and breast mastectomy flap necrosis (3.0%). Seventy-six (63.9%) patients had no complications. Overall success rate of flap reconstruction was 100%.
[CONCLUSION] Collaboration among surgery, anesthesia, and dedicated nursing teams allow 23-hour observation or outpatient DIEP reconstruction to be safe and feasible. By attaining equivalency with implant-based reconstruction, access to flap reconstruction can be extended to more patients.
[METHODS] A retrospective review was performed of patients who underwent free flap breast reconstruction by a single surgeon from November 2021 to May 2024. Demographics, operative details, opioid ingestion, length of stay, and postoperative complications were reviewed to assess safety of discharge in 24 hours.
[RESULTS] One hundred sixty-four DIEP flaps were performed on 119 patients. Average length of stay was 1.5 days (SD 0.7 days), with 67 (56.3%) patients discharged on postoperative day 1 (POD1) and 52 (43.7%) discharged after POD1. Of those discharged on POD1, 13 (19.4%) went home in <24 hours. Comparing patients discharged on POD1 to those discharged after POD1, there were statistically significant differences in reconstruction laterality (76.1% vs 44.2% unilateral, p<0.001), operative time (341.0 vs 439.1 minutes, p<0.001), and opioid ingestion on POD1 (4.2 IV morphine milligram equivalents [MME] vs 11.3 MME, p<0.001). Common complications included abdominal wound dehiscence (10.1%), abdominal seroma (5.0%), breast wound dehiscence (4.9%), and breast mastectomy flap necrosis (3.0%). Seventy-six (63.9%) patients had no complications. Overall success rate of flap reconstruction was 100%.
[CONCLUSION] Collaboration among surgery, anesthesia, and dedicated nursing teams allow 23-hour observation or outpatient DIEP reconstruction to be safe and feasible. By attaining equivalency with implant-based reconstruction, access to flap reconstruction can be extended to more patients.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 해부 | breast
|
유방 | dict | 5 | |
| 시술 | flap
|
피판재건술 | dict | 4 | |
| 합병증 | wound dehiscence
|
상처열개 | dict | 2 | |
| 시술 | free flap
|
피판재건술 | dict | 1 | |
| 합병증 | seroma
|
장액종 | dict | 1 | |
| 합병증 | flap necrosis
|
괴사 | dict | 1 | |
| 합병증 | flap breast
|
scispacy | 1 | ||
| 합병증 | abdominal wound
|
scispacy | 1 | ||
| 합병증 | abdominal seroma
|
scispacy | 1 | ||
| 합병증 | 23-hour
|
scispacy | 1 | ||
| 약물 | morphine
|
C0026549
morphine
|
scispacy | 1 | |
| 약물 | equivalents [MME]
|
scispacy | 1 | ||
| 약물 | MME
|
C0066662
1,2,3,4,9,9-hexachloro-1,4,4a,5,8,8a-hexahydro-6- methyl-6,7-epoxy-1,4-methanonaphthalene
|
scispacy | 1 | |
| 약물 | [BACKGROUND]
|
scispacy | 1 | ||
| 약물 | opioid
|
scispacy | 1 | ||
| 약물 | [RESULTS] One hundred sixty-four DIEP flaps
|
scispacy | 1 | ||
| 질환 | DIEP
→ deep inferior epigastric perforator
|
scispacy | 1 | ||
| 질환 | abdominal wound dehiscence
|
scispacy | 1 | ||
| 질환 | abdominal seroma
|
scispacy | 1 | ||
| 질환 | breast wound dehiscence
|
scispacy | 1 | ||
| 질환 | necrosis
|
C0027540
Necrosis
|
scispacy | 1 | |
| 질환 | breast wound
|
scispacy | 1 | ||
| 질환 | breast mastectomy flap
|
scispacy | 1 | ||
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | POD1
→ postoperative day 1
|
scispacy | 1 | ||
| 기타 | POD1 (4.2 IV morphine milligram equivalents [MME
|
scispacy | 1 | ||
| 기타 | MME
|
scispacy | 1 | ||
| 기타 | DIEP
→ deep inferior epigastric perforator
|
scispacy | 1 | ||
| 기타 | implant-based
|
scispacy | 1 |
MeSH Terms
Humans; Mammaplasty; Female; Retrospective Studies; Perforator Flap; Middle Aged; Patient Discharge; Length of Stay; Epigastric Arteries; Adult; Postoperative Complications; Feasibility Studies; Time Factors; Aged; Operative Time
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Endodontic implications of hypercementosis: A systematic review of anatomical challenges and therapeutic strategies.
- The impact of three-dimensional simulation and virtual reality technologies on surgical decision-making and postoperative satisfaction in aesthetic surgery: a preliminary study.
- Cutaneous fistula of the breast: A complication of cosmetic autologous fat transfer.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Breast plastic surgery in perimenopausal and postmenopausal women: Menopause-informed counseling on screening, safety, and long-term breast health.